Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

ER-to-School asthma program aims to keep kids out of the hospital

NCT ID NCT03952286

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to help children with asthma take their medicine properly. Kids who came to the emergency room for an asthma attack were given their medications right there, and then school staff supervised their daily use. The goal was to see if this approach could reduce repeat ER visits. Only 13 children took part, so the results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
prednisolone, budesonide, albuterol sulfate
What this could lead to
If it works, this approach could help children with asthma stay healthier and avoid repeated emergency room visits.
What could go wrong
This is a very small, early feasibility study with only 13 participants, so results may not apply to all children. The intervention also requires school cooperation, which may not be available everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

13 people

The number who actually took part.

Started

Aug 2019

Finished

Jan 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Children 6-12 years of age; AND 2. Treated for an asthma exacerbation as determined clinically by the principal ED provider based on symptoms such as shortness-of-breath, cough, and wheezing; AND 3. Symptoms must improve following more than 1 dose of albuterol and more than 1 dose of systemic corticosteroids such that he/she can be safely discharged home; AND 4. Must have physician-diagnosed Exclusion Criteria: 1. Attends a non-participating school; OR 2. Attends a participating school less than 5x/week; OR 3. Enrolled in another research study; OR 4. Patients who are hospitalized; OR 5. The patient or their consenting parent/guardian does not speak English or Spanish; OR 6. ICU admissions for asthma in the past year; OR 7. History of more than 2 hospitalizations for asthma in past year; OR 8. History of more than 2 controller medications for asthma in the past 30 days; OR 9. Study medication represents a step-down in asthma therapy in the judgement of the ED physician; OR 10. Parent does not have a cell phone; OR 11. Parent cannot send and receive text messages.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asthma & Airway Disease Research Center

    Tucson, Arizona, 85724, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.